Company Filing History:
Years Active: 2013
Title: Jörg Diefenbach: Innovator in Pharmaceutical Chemistry
Introduction
Jörg Diefenbach is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as effective inhibitors for specific enzymes.
Latest Patents
Diefenbach holds a patent for "Substituted 7-carboxamido-pyrrolo[3,2-d]pyrimidines." This patent describes compounds of Formula (I), where R1, R21, R22, R23, R24, Y, and R3 have specific meanings as outlined in the patent description. The compounds, along with their salts, N-oxides, and stereoisomers, are recognized for their effectiveness as inhibitors of type 5 phosphodiesterase. He has 1 patent to his name.
Career Highlights
Jörg Diefenbach is currently employed at Takeda GmbH, a leading global pharmaceutical company. His work focuses on innovative solutions in drug development, contributing to advancements in therapeutic options for various medical conditions.
Collaborations
Throughout his career, Diefenbach has collaborated with esteemed colleagues, including Josef Stadlwieser and Beate Schmidt. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
Jörg Diefenbach's contributions to pharmaceutical chemistry and his innovative patent work exemplify his commitment to advancing medical science. His ongoing efforts at Takeda GmbH continue to impact the field positively.